Martin Shkreli, the investor and convicted securities fraudster widely referred to as “Pharma Bro,” has claimed that he and ...
Infamous "Pharma Bro" Martin shkreli is still making things difficult for the new owner of a legendary Wu-Tang Clan album.
Martin Shkreli, the infamous former pharmaceutical executive, recently made an intriguing comment on social media platform X, hinting at his prison life. This comes as Changpeng Zhao, the co ...
Why do they call Martin shkreli Pharma Bro? Mr. Shrkeli played a major role in driving up the price of Daraprim, a toxoplasmosis drug, which the Swiss company owns the rights to, earning him the ...
Former pharma executive Martin Shkreli, who became notorious for raising the price of a lifesaving AIDS drug by around 5,000%, has been released early from his seven-year prison term for ...
On Thursday, Martin Shkreli was told he would face trial for fraud -- but the pharmaceutical executive appeared to have other, more pressing issues on his mind. On the top of that list was ...
Jury selection kicked off Monday in New York for the next chapter of a federal securities trial that could open up the cell adjoining convicted fraudster Martin Shkreli’s for his former lawyer.
If you buy through a BGR link, we may earn an affiliate commission, helping support our expert product labs. “Pharma Bro” Martin Shkreli is one of the most disliked people living in the United ...
In a Spaces interview on X, 'Pharma Bro' Martin Shkreli alleged that he created the DJT cryptocurrency with Barron Trump. Convicted Pharma Bro Martin Shkreli makes surprise appearance at SBF trial ...
Well Go USA’s Cold Wallet turns the real perils of crypto investing into a darkly funny home invasion thriller.
A New York federal judge ordered Martin Shkreli to surrender any copies of the one-of-a-kind Wu-Tang Clan album "Once Upon a Time in Shaolin" in response to a complaint from the record's new owner.
Martin Shkreli was sentenced to seven years in prison last year for looting a drug company he founded, Retrophin, of $11 million to pay back investors in two failed hedge funds he ran. Martin ...